ETON- Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. (ETON) has 8 insiders with recent SEC Form 4 filings, including 14 buys and 12 sells. ETON is classified in the Pharmaceuticals industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.05M | $98.58M | - | |
| Other | 630.2K | $20.39M | - | |
| Dir | 295.2K | $9.55M | - | |
| Dir | 286.5K | $9.27M | - | |
| Dir | 286.5K | $9.27M | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Adams Jennifer McKie | Director | Sale+OE | 50,000 | $32.48 | $1,623,795.00 | -100% | - | - | |
| Aug 20, 2025 | Gruber James R. | Chief Financial Officer | Sell | 41,713 | $16.15 | $673,713.74 | -9.2% | +3.9% | - | |
| Jun 16, 2025 | Krempa David | Chief Business Officer | Sell | 34,000 | $14.83 | $504,317.63 | -1.8% | +25.5% | +128.3% | |
| Jun 10, 2025 | Opaleye Management Inc.60 | 10% Owner | Buy | 7,930 | $15.82 | $125,483.53 | +0.3% | +13.2% | +85.4% | |
| Jun 5, 2025 | Brynjelsen Sean | President &CEO | Sell | 210,000 | $17.11 | $3,592,611.00 | -1.4% | +1.2% | +68.9% | |
| Oct 23, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 10,000 | $7.98 | $79,814.00 | +0.4% | +87.8% | +128.0% | |
| Oct 8, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 62,070 | $6.99 | $434,136.74 | +0.7% | +64.3% | +182.8% | |
| Sep 11, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 107,500 | $4.70 | $504,875.00 | +2.0% | +151.4% | +266.8% | |
| Sep 22, 2022 | Brynjelsen Sean | Chief Executive Officer | Buy | 10,000 | $2.10 | $21,042.00 | +1.0% | +33.2% | +113.8% | |
| Nov 17, 2021 | Opaleye Management Inc.60 | 10% Owner | Sell | 25,000 | $4.67 | $116,712.50 | -1.0% | -16.8% | -36.3% |
Page 1Next →